N/A
N=100
Evaluation of Retinal Microvascular Change That May Develop in After Open Globe Injury
Eye Injury Trauma
Bottom Line
View on ClinicalTrials.gov: NCT05771467 ↗Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcome: Primary: Corneal Thickness — 542.23; 546.16; 544.32 microns
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Comprehensive Ophthalmologic Examination (Diagnostic_test)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Akdeniz University
- Primary completion
- Sep 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Corneal Thickness |
542.23; 546.16; 544.32 | — |
| PRIMARY Anterior Chamber Volume |
177.97; 165.9 | — |
| PRIMARY Anterior Chamber Depth |
2.93; 3.05 | — |
| PRIMARY Anterior Chamber Angle |
38.87; 37.8 | — |
| PRIMARY Lens Power |
20.98; 20.26 | — |
| PRIMARY Steep Keratometry |
44.22; 44.57 | — |
| PRIMARY Tonometry |
14.74; 15.78 | — |
| PRIMARY Axial Length |
23.86; 23.36 | — |
| PRIMARY Optic Nerve Head Vessel Density |
23.22; 25.2 | — |
| PRIMARY Choriocapillaris Flow Area |
36.88; 36.53 | — |
| PRIMARY Subfoveal Central Macular Thickness |
321.42; 311.57 | — |
Summary
The aim of this study is to evaluate posterior segment changes in the non-traumatic eye after open globe injury.
Eligibility Criteria
Inclusion Criteria
- Be over 18 years old
- Unilateral eye injury
Exclusion Criteria
- Be under the age of 18
- Usage of systemic drugs or topical ocular drops
- Bilateral eye injury
- Having systemic disease, having ocular pathology that may decrease visual acuity
Data sourced from ClinicalTrials.gov (NCT05771467). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.